A growth-factor stack combining IGF-1 LR3 with the GH secretagogues CJC-1295, ipamorelin, and GHRP-2. Component research lives on each peptide's page.
Composition
IGF-1 LR3 + GH secretagogues (CJC-1295, ipamorelin, GHRP-2) is a blend — it combines these research peptides, sold together as one item:
The evidence
A blend is only as studied as its parts. The reported findings below come from each peptide’s own research — grouped by compound so you always know which one a finding belongs to, and every claim links to the source it came from.
IGF-1 signaling effector downstream of GH-secretagogue stimulation
Research on this peptide is still being compiled — its page carries what's known so far.
See IGF1-LR3’s full profile →GH secretagogue
Reported routines
GH secretagogue
Reported routines
GH secretagogue
Reported routines
See where IGF-1 LR3 + GH secretagogues (CJC-1295, ipamorelin, GHRP-2) fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Wondering how IGF-1 LR3 + GH secretagogues (CJC-1295, ipamorelin, GHRP-2) pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.